|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Cash and due from banks | ||||||||||||||||||||
| Interest-bearing deposits in depository institutions | ||||||||||||||||||||
| Cash and Cash Equivalents | ||||||||||||||||||||
| Investment securities available for sale, at fair value (amortized cost $1,583,311 and $1,602,721, net of allowance for credit losses of $0 at June 30, 2026 and December 31, 2025, respectively) | ||||||||||||||||||||
| Other securities | ||||||||||||||||||||
| Total Investment Securities | ||||||||||||||||||||
| Gross loans | ||||||||||||||||||||
| Allowance for credit losses | ||||||||||||||||||||
| Net Loans | ||||||||||||||||||||
| Bank owned life insurance | ||||||||||||||||||||
| Premises and equipment, net | ||||||||||||||||||||
| Accrued interest receivable | ||||||||||||||||||||
| Deferred tax assets, net | ||||||||||||||||||||
| Goodwill and other intangible assets, net | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total Assets | ||||||||||||||||||||
| Liabilities | ||||||||||||||||||||
| Deposits: | ||||||||||||||||||||
| Noninterest-bearing | ||||||||||||||||||||
| Interest-bearing: | ||||||||||||||||||||
| Demand deposits | ||||||||||||||||||||
| Savings deposits | ||||||||||||||||||||
| Time deposits | ||||||||||||||||||||
| Total Deposits | ||||||||||||||||||||
| FHLB short-term advances | ||||||||||||||||||||
| Customer repurchase agreements | ||||||||||||||||||||
| FHLB advances | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Total Liabilities | ||||||||||||||||||||
| Shareholders’ Equity | ||||||||||||||||||||
| Preferred stock, par value $25 per share: 500,000 shares authorized; none issued | ||||||||||||||||||||
| Common stock, par value $2.50 per share: 50,000,000 shares authorized; 19,047,548 shares issued at June 30, 2026 and December 31, 2025, less 4,995,538 and 4,693,613 shares in treasury, respectively | ||||||||||||||||||||
| Capital surplus | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Treasury Stock | ||||||||||||||||||||
| Accumulated other comprehensive loss: | ||||||||||||||||||||
| Unrealized loss on securities available-for-sale | ||||||||||||||||||||
| Underfunded pension liability | ||||||||||||||||||||
| Total Accumulated Other Comprehensive Loss | ||||||||||||||||||||
| Total Shareholders’ Equity | ||||||||||||||||||||
| Total Liabilities and Shareholders’ Equity | ||||||||||||||||||||
Loading...
